EMA Authorised: Verkazia (ciclosporin) — Santen Oy

View source ↗

Summary

EMA has authorised Verkazia (ciclosporin) from Santen Oy for the treatment of conjunctivitis and keratitis. The product has orphan medicinal status and underwen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivitis
• Keratitis

Drugs mentioned

• Verkazia (ciclosporin)

Snippet

Status: Authorised. Therapeutic area: Conjunctivitis;Keratitis. MAH: Santen Oy. Decision date: 31/03/2023. Orphan medicine. Accelerated assessment